Hepatitis C in blood donors
β Scribed by Irving, W.L.; Day, S.; Eglin, R.P.; Bennett, D.P.; Neal, K.R.; Jones, D.A.; James, V.
- Book ID
- 123333629
- Publisher
- The Lancet
- Year
- 1993
- Tongue
- English
- Weight
- 331 KB
- Volume
- 341
- Category
- Article
- ISSN
- 0140-6736
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Among 248 asymptomatic blood donors positive for anti-widespread in the blood donor population, that hepatitis C accounted for more than 90% of transfusion-transmitted body to hepatitis C virus (anti-HCV) enrolled in a long-term prospective study, 86% had chronic HCV infection and 14% hepatitis, and
Recently a recombinant polypeptide of hepatitis C virus (HCV) has been developed by the Chiton Corporation in California. This antigen has been used to develop an ELISA test (Ortho Diagnostic Systems for serum anti-HCV antibodies. Preliminary data have shown that this virus is the major cause of NAN